Pharmaceutical Industry and Drugs

Colgate-Palmolive Suffers Courtroom Loss in Asbestos-Talc Powder Case FairWarining Reports

Colgate-Palmolive Suffers Courtroom Loss in Asbestos-Talc Powder Case

Colgate-Palmolive Co. was ordered to pay $12.4 million in damages to a woman with a deadly form of cancer after a Los Angeles jury found that an asbestos-contaminated talcum powder was the main cause of her disease. The case was then settled today for an undisclosed amount as jurors were about to consider tacking on […]

Talc-Ovarian Cancer Link Sparks Growing Legal Battle FairWarining Investigates

Talc-Ovarian Cancer Link Sparks Growing Legal Battle

First of two stories
Deane Berg’s doctor called her in the day after Christmas, 2006, to give her the crushing news. She’d had her ovaries removed, the pathology results were back, and they could not have been much worse. Berg had stage III ovarian cancer, and her prognosis was poor. Despite her 25 years as a physician’s assistant, Berg, then 49, knew next to nothing about ovarian cancer. Grappling with the “why me?” question, she studied the risk factors […]

Cuban postage stamps touting the country's efforts to save limbs of diabetics (Photo by Andrew Schneider) FairWarining Investigates

As U.S. Bids to Renew Relations With Havana, Heralded Cuban Diabetes Drug Remains Off-Limits

HAVANA – President Obama’s efforts to renew relations with Cuba may soon allow Americans to visit this island’s pristine beaches and start lugging home shopping bags filled with long-coveted cigars and rum. But for frustrated American physicians battling to save the feet and legs of tens of thousands of diabetic patients, it may be a […]

FDA Panels Vote to Keep 'Black Box' Warning on Stop Smoking Drug Chantix FairWarining Reports

FDA Panels Vote to Keep ‘Black Box’ Warning on Stop Smoking Drug Chantix

On every package of the quit-smoking drug Chantix, a warning label alerts doctors and consumers that some people taking the tablets have reported “serious neuropsychiatric events.” As FairWarning has reported, Chantix’s so-called black box warning – the government’s strongest alert – was first imposed in 2009 after thousands of claims of side effects, including reported […]

Incredible Prices for Cancer Drugs

An unusually bold stand by doctors at the Memorial Sloan-Kettering Cancer Center in New York has forced a big drug company to reduce the cost of an overpriced drug for treating colorectal cancer that was no better than a cheaper competitor and did almost nothing to extend a patient’s life. It is a heartening sign […]

FDA Advisers Want Straight Talk About Risks on Labels for Birth Control Pills

After weighing the benefits of a new generation of birth control pills against potentially fatal blood clot risks associated with the drugs, federal scientific advisers have called for a regulatory compromise. Their recommendation to the Food and Drug Administration: Let the pills stay on the market, but require straight talk about the risks on the […]

Girls Under 17 Will Still Need a Prescription to Get ‘Morning After Pill’

The Obama administration has scuttled a proposal to make emergency contraceptives available to all women, including girls 16 and younger, without a prescription. In what the Los Angeles Times called an unexpected move, Health and Human Services Secretary Kathleen Sebelius rejected a decision by the Food and Drug Administration to permit a pill known as […]

Jury Awards $73 Million Over Pfizer Drugs’ Link to Breast Cancer

A Philadelphia jury has awarded $72.6 million to three women who sued Pfizer Inc., claiming that the pharmaceutical company’s menopause drugs caused them to develop breast cancer. The plaintiffs, all now in their 60s, for years took Prempro or related hormone replacement medications made by Pfizer’s Wyeth and Pharmacia Upjohn units. As Bloomberg reports, more […]

Senators Examine Pfizer Deal to Thwart Sales of Rival Generic Drugs

Time ran out this week on the patent for Pfizer’s blockbuster drug Lipitor, the top-selling medication for fighting cholesterol. The marketplace is beginning to open to competing generic versions of the drug. But, as The New York Times reports, Pfizer, with unprecedented  discount deals, found what could be a way to preserve much of its […]

China’s Plans for Vaccine Exports Raise Hopes and Fears

Chinese vaccine makers are gearing up to boost their exports over the next few years. The move is raising hopes that lower-cost immunizations will become available for the world’s poor — as well as fears that vaccine quality standards will be threatened. As USA Today reports, China captured world attention in 2009 when one of […]